Gillian Jalimnson
Gillian Jalimnson is one of Hemp Gazette's staff writers and has been with us since we kicked off in 2015. Gillian sees massive potential for cannabis in areas of health, energy, building and personal care products and is intrigued by the potential for cannabidiol (CBD) as an alternative to conventional treatments. You can contact Gillian here.
Thromboembolism Risk in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors: A Retrospective Study
Beyond Dopamine: New Research Uncovers Multisystem Brain Networks in Addiction Mechanisms
Cost-Utility Analysis Suggests Ezetimibe Addition to Statin Therapy May Be Cost-Effective for Acute Coronary Syndrome Management
Explainable AI Predicts CB1 Receptor Affinity and Potency for Cannabinoids and NPS
Federally Funded Study Links Cannabis Access to Reductions in Non-Fatal Opioid Overdoses
Isle of Man Tynwald Questions Hospital Protocol for Medicinal Cannabis Patients
Exploring the Interplay of Medical Cannabis, the HPA Axis, and Inflammation in Depression Research
Understanding Gen Z's Self-Reported Cannabis Use Patterns: Insights from a Recent Survey
Australian and New Zealand Cannabinoid Medicine Organisations Near Merger Completion
Federally Funded Study Explores Medicinal Cannabis Extract for Weight Management and Glucose Regulation in Preclinical Models

